-+ 0.00%
-+ 0.00%
-+ 0.00%
Xilio Therapeutics names Ben Harshbarger chief legal officer
Share
Listen to the news
Xilio Therapeutics names Ben Harshbarger chief legal officer
  • Xilio Therapeutics appointed Ben Harshbarger as chief legal officer.
  • Harshbarger most recently served as chief legal officer at Astria Therapeutics until its acquisition by BioCryst Pharmaceuticals.
  • He previously held senior legal leadership roles at Novelion Therapeutics, Aegerion Pharmaceuticals, Cubist Pharmaceuticals, ViaCell, and Biogen.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606290730PRIMZONEFULLFEED9753402) on June 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending